• FDA to Review Lynparza Extension for Certain Advanced Breast Cancer Patients
  • Mundipharma EDO Begins Phase 1/2 Trial of Tinostamustine in Triple Negative Breast Cancer, Other Solid Tumors
  • Breast Cancer Death Rates Drop, but Racial Disparities Remain, American Cancer Society Reports
  • First Breast Cancer Patient in Japanese Trial Receives Entinostat
  • Researchers Develop New Strategy to Target Breast Cancer Metastasis in Bones
  • Synergys Awarded NCI Grant to Develop SYN001 for Triple-negative Breast Cancer
  • The Angelina Jolie Effect Was Real, Hard Data in US and Australia Confirms
  • Physical Activity Boosts Breast Cancer Survivors’ Cognition, Study Reports
  • FDA Approves Eli Lilly’s Verzenio for Certain Types of Breast Cancer
  • Nerlynx Delays Invasive Disease in Breast Cancer Patients Treated with Herceptin, ExteNET Trial Shows
  • Novartis, Eva Longoria Launch ‘Kiss This 4 MBC’ to Raise Funds, Awareness for Metastatic Breast Cancer
  • Tibetan Yoga May Improve Sleep Quality in Breast Cancer Patients on Chemotherapy, Study Finds